← Open Payments lookup

MELISSA SHEPARD: Open Payments

NPI 1396565206 · HENSLEY, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$730 in 39 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $730

Food & beverage: $730
CompanyPaymentsAmount
ABBVIE INC.10$168
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$162
AstraZeneca Pharmaceuticals LP5$87
Axsome Therapeutics, Inc.4$86
GlaxoSmithKline, LLC.5$81
Dexcom, Inc.2$46
Novo Nordisk Inc2$39
Antares Pharma, Inc.1$25
Paratek Pharmaceuticals, Inc.1$22
Lilly USA, LLC1$14

Products named: CAPLYTA, UBRELVY, AIRSUPRA, Auvelity, TRELEGY ELLIPTA, Dexcom G6 Transmitter, VRAYLAR, XYOSTED.

Industry payments across AR — which companies pay providers there.